Your browser doesn't support javascript.
loading
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting.
Seitz, Christian M; Mittelstaet, Joerg; Atar, Daniel; Hau, Jana; Reiter, Selina; Illi, Clara; Kieble, Verena; Engert, Fabian; Drees, Britta; Bender, Giulia; Krahl, Ann-Christin; Knopf, Philipp; Schroeder, Sarah; Paulsen, Nikolas; Rokhvarguer, Alexander; Scheuermann, Sophia; Rapp, Elena; Mast, Anna-Sophia; Rabsteyn, Armin; Schleicher, Sabine; Grote, Stefan; Schilbach, Karin; Kneilling, Manfred; Pichler, Bernd; Lock, Dominik; Kotter, Bettina; Dapa, Sandra; Miltenyi, Stefan; Kaiser, Andrew; Lang, Peter; Handgretinger, Rupert; Schlegel, Patrick.
Afiliación
  • Seitz CM; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Mittelstaet J; R&D Department, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
  • Atar D; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Hau J; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Reiter S; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Illi C; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Kieble V; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Engert F; R&D Department, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
  • Drees B; R&D Department, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
  • Bender G; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Krahl AC; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Knopf P; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany.
  • Schroeder S; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Paulsen N; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Rokhvarguer A; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Scheuermann S; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Rapp E; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Mast AS; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Rabsteyn A; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Schleicher S; Cluster of Excellence iFIT (Exc 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tuebingen, Germany.
  • Grote S; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Schilbach K; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Kneilling M; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Germany.
  • Pichler B; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany.
  • Lock D; Cluster of Excellence iFIT (Exc 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tuebingen, Germany.
  • Kotter B; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany.
  • Dapa S; Cluster of Excellence iFIT (Exc 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tuebingen, Germany.
  • Miltenyi S; R&D Department, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
  • Kaiser A; R&D Department, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
  • Lang P; R&D Department, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
  • Handgretinger R; R&D Department, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
  • Schlegel P; R&D Department, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
Oncoimmunology ; 10(1): 2003532, 2021.
Article en En | MEDLINE | ID: mdl-35686214
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Neoplasias Tipo de estudio: Qualitative_research Límite: Animals Idioma: En Revista: Oncoimmunology Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Neoplasias Tipo de estudio: Qualitative_research Límite: Animals Idioma: En Revista: Oncoimmunology Año: 2021 Tipo del documento: Article País de afiliación: Alemania